Impact of Pemafibrate Therapy on Reducing Small Dense Low-Density-Lipoprotein-Cholesterol Levels in Patients with Hypertriglyceridemia

Background: Small dense LDL-cholesterol is a recently discovered cardiovascular risk factor beyond LDL-cholesterol. Pemafibrate is a novel selective peroxisome proliferator-activated receptor-α modulator that reduces triglyceride levels. Given the significant association between triglycerides and sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hida, Yuki, Imamura, Teruhiko, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648094/
https://www.ncbi.nlm.nih.gov/pubmed/37959379
http://dx.doi.org/10.3390/jcm12216915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648094/
https://www.ncbi.nlm.nih.gov/pubmed/37959379
http://dx.doi.org/10.3390/jcm12216915

Ejemplares similares